Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

041IC - AUA Guidelines: Evaluation & Management of Localized Renal Mass, Case-Based Approach

Sunday, May 20
7:30 AM - 9:30 AM
Location: MCC WEST, 2008

This course will review the management of clinically localized renal masses and the recent AUA Guidelines that apply to this. This will include a review of tumor biology and the potential role of renal mass biopsy. Guidelines recommendations for patient evaluation and counseling will also be reviewed, and the current role for all of the major management strategies will be discussed. Oncologic and functional considerations, and perioperative risk profiles will be reviewed for partial nephrectomy, radical nephrectomy, thermal ablation, and active surveillance.

Learning Objectives:

Steven Campbell

Cleveland Clinic

Dr. Campbell obtained BS/MD/PhD degrees at University Chicago and then did a Urology Residency at Cleveland Clinic(1989-1995), followed by a fellowship in Urologic Oncology at MSKCC (1995-1996). Dr. Campbell’s primary interests include RCC, bladder cancer, angiogenesis, and urology residency training. His background also includes AFUD and Kimmel Scholarship Awards. He has served as Chair of the Exam Committee for the Society of Urologic Oncology and Secretary/Treasurer for the Society of Pelvic Surgeons. Dr. Campbell is current Chair for the AUA Guidelines Panel for Management of Localized Kidney Cancer, and was Co-Chair for the previous iteration of this in 2009. Dr. Campbell is Co-Editor of Renal Cell Carcinoma (BC Decker, 2009) and Editor of Renal Cell Carcinoma: Clinical Management (Humana Press, 2013) and 100 Questions and Answers about Kidney Cancer (Jones and Bartlett, 2008, 2012, and 2015). Dr. Campbell has also authored or co-authored “Malignant Renal Tumors” for Campbell/Walsh Urology for the past 4 editions (2000, 2005, 2010, and 2015).

In the past 4 years Dr. Campbell has published primary and review articles on the Management of Small Renal Masses, Techniques of Partial Nephrectomy, Determinants of Renal Function after Partial Nephrectomy, Chronic Kidney Disease (CKD) and its Implications for Urologists, New Perspectives about Acute Kidney Injury, Renal Mass Biopsy, Imaging of Renal Masses, Management of RCC in the Elderly, Benign Renal Masses, Targeted Treatment for Advanced Kidney Cancer, Integration of Surgery and Targeted Treatment for Advanced Kidney Cancer, Staging of Kidney Cancer, and Surveillance of Kidney Cancer Patients after Primary Treatment. In 2016 his efforts are primarily focused on the Implications of CKD due to Surgical Removal of Nephrons, the Relative Importance of Ischemia with Respect to Recovery of Function after Partial Nephrectomy, and neoadjuvant approaches for the management of patients with localized kidney cancer.


Send Email for Steven Campbell

Brian R. Lane

Spectrum Health; Michigan State University College of Human Medicine; Betz Family Endowed Chair for Cancer Research

Brian R. Lane, MD, PhD, FACS, is currently Chief of Urology at Spectrum Health Medical Group. He obtained his MD and PhD degrees in Cellular and Molecular Biology at the University of Michigan Medical School and then completed a Urology Residency and Fellowship in Urologic Oncology at the Cleveland Clinic. Dr. Lane was named an American Urologic Association Foundation Scholar and is a former member of the American Council for Graduate Medical Education Review Committee for Urology. Dr. Lane is an active Clinical Champion for the Michigan Urological Surgery Improvement Collaborative (MUSIC), a physician-led quality improvement collaborative comprised of a consortium of urology practices across the state of Michigan. He currently is the Director of Robotic Surgery in the Department of Surgical Subspecialties as well as the Physician Lead in the Robotic and Advanced Minimally Invasive Surgery Program at Spectrum Health. In addition, Dr. Lane is an Associate Professor in the Department of Surgery at Michigan State University. His primary clinical interests include kidney cancer, prostate cancer, bladder cancer, testicular cancer, and adrenal cancer. He has authored more than 150 peer-reviewed publications in urology and oncology.


Send Email for Brian Lane

Phillip M. Pierorazio

Johns Hopkins

Dr. Phillip Pierorazio is an Associate Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins. Dr. Pierorazio is originally from New York, received his undergraduate degree from Georgetown University (Washington DC) and his medical degree from Columbia University, College of Physicians & Surgeons (New York City) where he completed a Doris Duke Clinical Research Fellowship in Urologic Oncology.

Dr. Pierorazio has expertise in all malignancies of the urinary tract and performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder, prostate and retroperitoneal lymph node dissection for testicular cancer. He has a special interest in kidney cancer, including partial nephrectomy for early stage disease and high-risk surgeries for patients with advanced cancers.

His research interests parallel his clinical practice, including high-risk prostate and urothelial cancer. He has a special interest in testicular (see below) and kidney cancer (renal cell carcinoma), studying both advanced and early-stage disease. He runs the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry - one of the largest active surveillance registries for patients with small kidney tumors. He sits on both the AUA and National Comprehensive Cancer Network (NCCN) Guidelines Committees for Kidney Cancer.

He is also the Director of the Division of Testicular Cancer, a member of the NCCN and AUA Guidelines committee, and works with a number of testicular cancer advocacy groups around the country. He runs the testicular cancer "Go-Team" and coordinates the departments research efforts in testicular cancer.

Dr. Pierorazio is the recipient of a number of academic awards including the American Urologic Association Essay Contest, NCCN Young Investigator Award, and has presented his research at a number of national and international meetings. He has written and published numerous research articles, textbook chapters, and video presentations in the field Urologic Oncology.


Send Email for Phillip Pierorazio

Robert Uzzo

Fox Chase Cancer Center - Temple Health

Dr. Uzzo graduated summa cum laude and valedictorian from Union College in upstate New York as part of their accelerated 6 year biomedical program. He attended Cornell University Medical College where he graduated in 1991 and was a New York State Finalist for the Rhodes Scholarship Competition. He completed general surgical training followed by urologic surgical training at New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. He was an American Foundation for Urological Diseases Scholar in Urological Oncology and completed both Oncological and Renal Transplantation Fellowships at the Cleveland Clinic.

Dr. Uzzo is currently the Chairman of the Department of Surgery at Fox Chase Cancer Center. He serves as the G. Willing “Wing” Pepper Professor of Urological Oncology at Fox Chase Cancer Center/Temple University. He is also the Chair of the Fox Chase/Einstein Urologic Institute.

Dr Uzzo has authored over 350 peer-reviewed articles in urologic oncology primarily focused on renal, prostate and bladder cancer. He is also the author of more than 30 chapters including the senior author of “Pathophysiology, Evaluation and Medical Management of Adrenal Disorders” In Campbell’s Urology. He is a Diplomat of the American Board of Urology, a Fellow of the American College of Surgeons, and a member of the American Association of Genitourinary Surgeons. He is a member of numerous additional medical societies including the AUA, ASCO, SUO and ECOG. He is heavily involved in clinic trials in urologic oncology as a Principle Investigator, co-investigator and president of the Society of Urologic Oncology – Clinical Trials Consortium. He has presented over 350 times nationally and internationally on topics in urologic oncology and has been a visiting professor at over 25 universities and medical centers worldwide. He is on the editorial board and a peer reviewer for 15 medical journals.


Send Email for Robert Uzzo


041IC - AUA Guidelines: Evaluation & Management of Localized Renal Mass, Case-Based Approach


Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for AUA Guidelines: Evaluation & Management of Localized Renal Mass, Case-Based Approach